MARIE HARTLEY: Open Payments
NPI 1386731115 · HARWICH, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$314 in 16 payments from 10 companies in 2025. Trend: 2023 $38 · 2024 $592 · 2025 $314
Food & beverage: $314
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $63 |
| Novartis Pharmaceuticals Corporation | 3 | $48 |
| Amgen Inc. | 2 | $47 |
| Xeris Pharmaceuticals, Inc. | 2 | $42 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $35 |
| Lilly USA, LLC | 1 | $19 |
| Novo Nordisk Inc | 1 | $18 |
| RGH Enterprises LLC | 1 | $16 |
| Acella Pharmaceuticals, LLC | 1 | $14 |
| BETA BIONICS, INC. | 1 | $11 |
Products named: QULIPTA, LEQVIO, EVENITY, RECORLEV, Kerendia, MOUNJARO, Wegovy, NP Thyroid 60.
Industry payments across MA — which companies pay providers there.
